Login Register Cart 0
Generic placeholder image

Infectious Disorders - Drug Targets

Editor-in-Chief

ISSN (Print): 1871-5265
ISSN (Online): 2212-3989

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Resistance Pattern in Mostly Gram-negative Bacteria Causing Urinary Tract Infections

Author(s): Bader S. Alotaibi, Bilal Ahmad Tantry, Anjum Farhana, Muath A. Alammar, Naveed Nazir Shah, Abdul Hafeez Mohammed, Farooq Wani and Altaf Bandy*

Volume 23, Issue 2, 2023

Published on: 21 October, 2022

Article ID: e280922209238 Pages: 9

DOI: 10.2174/1871526522666220928115043

Price: $65

Abstract

Purpose: The antimicrobial prescription in urinary tract infections (UTI) is driven by local data on its pathogenic spectrum and the resistance pattern exhibited by the disease-causing pathogens.

We aimed to determine the bacteriological diversity of UTI causing pathogens and antimicrobial resistance in mostly gram-negative bacteria.

Methods: This retrospective hospital-based cross-sectional study analyzed the culture and sensitivity reports of urine samples from a referral centre in the Aljouf region of Saudi Arabia. All the antibiograms from January 1, 2020, to December 31st 2020, were included. The bacterial identification and antimicrobial testing were carried out by the BD Phoenix system (BD Diagnostics, Sparks, MD, USA). Antimicrobial testing was performed as per the Clinical and Laboratory Standard Institute recommendations. Frequencies of multidrug- and extensive drug resistance were calculated.

Results: Of the 1334 non-duplicate urine samples received, 422 (31.6%) bacterial growths were observed. Of these, 383 (90.8%) and 39 (9.2%) were gram-negative and gram-positive bacterial isolations, respectively. E. coli 161 (38.1%), K. pneumoniae 97 (23.0%), and E. faecalis 18 (4.3%) were frequent aetiologies of UTI. 309 (80.7%) of gram-negative bacteria were multidrug-resistant including 88 (23.0%) extensively drug-resistant. Overall, a resistance rate of > 55 % to 1st through 4th generation cephalosporins was observed except for cefoxitin (43.7%). A resistance rate of 37.6% was observed towards carbapenems, with the lowest rate (34.0%) to meropenem.

Conclusion: Multi-drug resistant gram-negative bacteria dominate the pathogenic spectrum of UTI in the region. A high resistance rate to cephalosporins and carbapenems exists in gram-negative organisms, causing UTI.

Keywords: Urinary tract infections, Gram-negative bacteria, antimicrobial resistance, multidrug-resistance, carbapenems, meropenem.

Graphical Abstract

[1]
Ahmed SS, Shariq A, Alsalloom AA, Babikir IH, Alhomoud BN. Uropathogens and their antimicrobial resistance patterns: Relationship with urinary tract infections. Int J Health Sci 2019; 13(2): 48-55.
[PMID: 30983946]
[2]
Foxman B. Urinary tract infection syndromes: Occurrence, recurrence, bacteriology, risk factors, and disease burden. Infect Dis Clin North Am 2014; 28(1): 1-13.
[http://dx.doi.org/10.1016/j.idc.2013.09.003] [PMID: 24484571]
[3]
Hooton TM. Clinical practice. Uncomplicated urinary tract infection. N Engl J Med 2012; 366(11): 1028-37.
[http://dx.doi.org/10.1056/NEJMcp1104429] [PMID: 22417256]
[4]
Alanazi MQ. An evaluation of community-acquired urinary tract infection and appropriateness of treatment in an emergency department in Saudi Arabia. Ther Clin Risk Manag 2018; 14: 2363-73.
[http://dx.doi.org/10.2147/TCRM.S178855] [PMID: 30584311]
[5]
Kumar MS, Ghosh S, Nayak S, Das AP. Recent advances in biosensor based diagnosis of urinary tract infection. Biosens Bioelectron 2016; 80: 497-510.
[http://dx.doi.org/10.1016/j.bios.2016.02.023] [PMID: 26890825]
[6]
Akoachere JFTK, Yvonne S, Akum NH, Seraphine EN. Etiologic profile and antimicrobial susceptibility of community-acquired urinary tract infection in two Cameroonian towns. BMC Res Notes 2012; 5(1): 219.
[http://dx.doi.org/10.1186/1756-0500-5-219] [PMID: 22564344]
[7]
Nzalie RN, Gonsu HK, Koulla-Shiro S. Bacterial etiology and antibiotic resistance profile of community-acquired urinary tract infections in a Cameroonian City. Int J Microbiol 2016; 2016: 1-6.
[http://dx.doi.org/10.1155/2016/3240268] [PMID: 27667998]
[8]
Alamri A, Hamid M, Abid M, et al. Trend analysis of bacterial uropathogens and their susceptibility pattern: A 4-year (2013–2016) study from Aseer region, Saudi Arabia. Urol Ann 2018; 10(1): 41-6.
[http://dx.doi.org/10.4103/UA.UA_68_17] [PMID: 29416274]
[9]
Behzadi P, Behzadi E, Yazdanbod H, Aghapour R, Akbari CM, Salehian OD. A survey on urinary tract infections associated with the three most common uropathogenic bacteria. Maedica 2010; 5(2): 111-5.
[PMID: 21977133]
[10]
Al Wutayd O, Al Nafeesah A, Adam I, Babikir I. The antibiotic susceptibility patterns of uropathogens isolated in Qassim, Saudi Arabia‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬. J Infect Dev Ctries 2018; 12(11): 946-52.
[http://dx.doi.org/10.3855/jidc.10553] [PMID: 32012123]
[11]
Shapiro DJ, Hicks LA, Pavia AT, Hersh AL. Antibiotic prescribing for adults in ambulatory care in the USA, 2007–09. J Antimicrob Chemother 2014; 69(1): 234-40.
[http://dx.doi.org/10.1093/jac/dkt301] [PMID: 23887867]
[12]
Kobayashi M, Shapiro DJ, Hersh AL, Sanchez GV, Hicks LA. Outpatient antibiotic prescribing practices for uncomplicated urinary tract infection in women in the United States, 2002–2011. Open Forum Infect Dis 2016; 3(3): ofw159.
[http://dx.doi.org/10.1093/ofid/ofw159] [PMID: 27704014]
[13]
Organization WH. The World Health Report 2007: A Safer Future: Global Public Health Security in the 21st Century, World Health Organization2007. World Health 2007. Available from: https://www.who.int/publications/i/item/9789241563444
[14]
Ashley B, Hay AD, Lane IF, Thornton HV, Mandy W, Costelloe C. Global prevalence of antibiotic resistance in paediatric urinary tract infections caused by escherichia coli and association with routine use of antibiotics in primary care: Systematic review and meta-analysis. BMJ 2013; 352: i939.
[15]
Patel JB. Performance standards for antimicrobial susceptibility testing. Clinical and Laboratory Standards Institute, Wayne 2017.
[16]
Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: An interna-tional expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 2012; 18(3): 268-81.
[http://dx.doi.org/10.1111/j.1469-0691.2011.03570.x] [PMID: 21793988]
[17]
Vasudevan R. Urinary tract infection: An overview of the infection and the associated risk factors. J Microbiol Exp 2014; 1(2): 42-54.
[http://dx.doi.org/10.15406/jmen.2014.01.00008]
[18]
Gupta K. Emerging antibiotic resistance in urinary tract pathogens. Infect Dis Clin North Am 2003; 17(2): 243-59.
[http://dx.doi.org/10.1016/S0891-5520(03)00006-0] [PMID: 12848469]
[19]
Taher I, Almaeen A, Aljourfi H, et al. Surveillance of antibiotic resistance among uropathogens in Aljouf region northern Saudi Arabia. Iran J Microbiol 2020; 11(6): 468-77.
[http://dx.doi.org/10.18502/ijm.v11i6.2218] [PMID: 32148678]
[20]
Minardi D, d’Anzeo G, Cantoro D, Conti A, Muzzonigro G. Urinary tract infections in women: Etiology and treatment options. Int J Gen Med 2011; 4: 333-43.
[http://dx.doi.org/10.2147/IJGM.S11767] [PMID: 21674026]
[21]
Yuan X, Liu T, Wu D, Wan Q. Epidemiology, susceptibility, and risk factors for acquisition of MDR/XDR Gram-negative bacteria among kidney transplant recipients with urinary tract infections. Infect Drug Resist 2018; 11: 707-15.
[http://dx.doi.org/10.2147/IDR.S163979] [PMID: 29785131]
[22]
Milovanovic T, Dumic I, Veličkovic J, Lalosevic MS, Nikolic V, Palibrk I. Epidemiology and risk factors for multi-drug resistant hospital-acquired urinary tract infection in patients with liver cirrhosis: Single center experience in Serbia. BMC Infect Dis 2019; 19(1): 141.
[http://dx.doi.org/10.1186/s12879-019-3761-5] [PMID: 30755176]
[23]
Gomila A, Shaw E, Carratalà J, et al. Predictive factors for multidrug-resistant gram-negative bacteria among hospitalised patients with complicated urinary tract infections. Antimicrob Resist Infect Control 2018; 7(1): 111.
[http://dx.doi.org/10.1186/s13756-018-0401-6] [PMID: 30220999]
[24]
Ibrahim Y, Sani Y, Saleh Q, Saleh A, Hakeem G. Phenotypic detection of extended spectrum beta lactamase and carbapenemase co-producing clinical isolates from two tertiary hospitals in Kano, North West Nigeria. Ethiop J Health Sci 2017; 27(1): 3-10.
[http://dx.doi.org/10.4314/ejhs.v27i1.2] [PMID: 28458485]
[25]
Shevade AG. β-lactamase production in uropathogens. Indian J Basic Appl Med Res 2013; 3: 206-8.
[26]
Akram M, Shahid M, Khan AU. Etiology and antibiotic resistance patterns of community-acquired urinary tract infections in J N M C Hospital Aligarh, India. Ann Clin Microbiol Antimicrob 2007; 6(1): 4.
[http://dx.doi.org/10.1186/1476-0711-6-4] [PMID: 17378940]
[27]
Parajuli NP, Maharjan P, Parajuli H, et al. High rates of multidrug resistance among uropathogenic Escherichia coli in children and analyses of ESBL producers from Nepal. Antimicrob Resist Infect Control 2017; 6(1): 9.
[http://dx.doi.org/10.1186/s13756-016-0168-6] [PMID: 28096977]
[28]
Livermore DM, Pearson A. Antibiotic resistance: Location, location, location. Clin Microbiol Infect 2007; 13 (Suppl. 2): 7-16.
[http://dx.doi.org/10.1111/j.1469-0691.2007.01724.x] [PMID: 17488371]
[29]
Kang JS, Yi J, Ko MK, Lee SO, Lee JE, Kim KH. Prevalence and risk factors of carbapenem-resistant enterobacteriaceae acquisition in an emergency intensive care unit in a Tertiary Hospital in Korea: A case-control study. J Korean Med Sci 2019; 34(18): e140.
[http://dx.doi.org/10.3346/jkms.2019.34.e140] [PMID: 31074254]
[30]
Al-Garni SM, Ghonaim MM, Ahmed MMM, Al-Ghamdi AS, Ganai FA. Risk factors and molecular features of extended-spectrum beta-lactamase producing bacteria at southwest of Saudi Arabia. Saudi Med J 2018; 39(12): 1186-94.
[http://dx.doi.org/10.15537/smj.2018.12.23273] [PMID: 30520499]
[31]
Paterson DL, Bonomo RA. Extended-spectrum beta-lactamases: A clinical update. Clin Microbiol Rev 2005; 18(4): 657-86.
[http://dx.doi.org/10.1128/CMR.18.4.657-686.2005] [PMID: 16223952]
[32]
Begum N, Shamsuzzaman SM. Emergence of multidrug resistant and extensively drug resistant community acquired uropathogens in Dhaka city, Bangladesh. Bangladesh J Med Microbiol 2017; 9(2): 7-12.
[http://dx.doi.org/10.3329/bjmm.v9i2.31414]
[33]
Al Mayahi Z, Kamel S, Amer H, Beatty M. Outbreak of colistin-resistant organisms at a tertiary hospital in Riyadh, Saudi Arabia, 2016. Pan Afr Med J 2019; 34: 162.
[http://dx.doi.org/10.11604/pamj.2019.34.162.19998] [PMID: 32153702]
[34]
Al-Zahrani J, Al Dossari K, Gabr AH, Ahmed A, Al Shahrani SA, Al-Ghamdi S. Antimicrobial resistance patterns of Uropathogens isolated from adult women with acute uncomplicated cystitis. BMC Microbiol 2019; 19(1): 237.
[http://dx.doi.org/10.1186/s12866-019-1612-6] [PMID: 31666014]
[35]
Hussein K, Raz-Pasteur A, Finkelstein R, et al. Impact of carbapenem resistance on the outcome of patients’ hospital-acquired bacteraemia caused by Klebsiella pneumoniae. J Hosp Infect 2013; 83(4): 307-13.
[http://dx.doi.org/10.1016/j.jhin.2012.10.012] [PMID: 23313086]
[36]
Shadi AZ. Antibiotic resistance in Saudi Arabia and some middle eastern countries: current status. Afr J Microbiol Res 2019; 13(8): 151-7.
[http://dx.doi.org/10.5897/AJMR2019.9048]
[37]
Elshamy A, Aboshanab K, Yassien M, Hassouna N. Prevalence of carbapenem resistance among multidrug-resistant Gram-negative uro-pathogens. Archiv Pharm Sci Ain Shams Univ 2018; 2(2): 70-7.
[http://dx.doi.org/10.21608/aps.2018.18736]
[38]
Ibrahim ME. Prevalence of Acinetobacter baumannii in Saudi Arabia: Risk factors, antimicrobial resistance patterns and mechanisms of carbapenem resistance. Ann Clin Microbiol Antimicrob 2019; 18(1): 1.
[http://dx.doi.org/10.1186/s12941-018-0301-x] [PMID: 30606201]
[39]
Tewari R, Chopra D, Wazahat R, Dhingra S, Dudeja M. Antimicrobial susceptibility patterns of an emerging multidrug resistant nosocomial pathogen: Acinetobacter baumannii. Malays J Med Sci 2018; 25(3): 129-34.
[http://dx.doi.org/10.21315/mjms2018.25.3.13] [PMID: 30899194]

Rights & Permissions Print Cite
Article Metrics
16
1
© 2024 Bentham Science Publishers | Privacy Policy